Delivery Order SPE2DB22D3501-SPE2DB25FVR90
Award Date
5/15/25
Potential Completion Date
6/6/25
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $16,244.96 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is a firm-fixed-price type, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract has a ceiling value of $7,796.30 and is a Firm Fixed Price contract. The ultimate completion date is September 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,796.30 and is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
This is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product, and has a ceiling value of $8,067.35. The contract is a firm-fixed price delivery order with a period of performance through January 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,484.74, is for the delivery of IBRANCE 125 MG CAPSULE 21S to DLA. It is a firm-fixed price, delivery order contract with a completion date of May 10, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product, with a ceiling value of $24,184.14 and a period of performance through March 7, 2025. The contract is a firm fixed-price, delivery order contract type. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ibrance 100 mg capsules, a prescription medication. The contract has a ceiling value of $8,122.48 and a performance period extending through May 16, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of IBRANCE 75 MG CAPSULE 21S medical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,797.84 and runs through November 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug IBRANCE 125 MG CAPSULE 21S. The contract has a ceiling value of $8,061.38 and runs through January 17, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,122.76, is for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 24, 2025. The award does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a...